Neuronal regulation and function of natriuretic peptide receptor C

Peptides

Volumn 26, Issue 6 SPEC. ISS., 2005, Pages 1060-1067

  Trachte, George ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adrenergic neurotransmission; Calcium; Natriuretic peptide receptor C

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIUM ION; NATRIURETIC PEPTIDE TYPE C; PROTEIN KINASE C;

ADRENERGIC TRANSMISSION; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; EVOKED RESPONSE; HUMAN; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 19444377575     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.08.029     Document Type: Article

References (38)

1. K. Atarashi, P.J. Mulrow, R. Franco-Saenz, R. Snajdar, and J. Rapp Inhibition of aldosterone production by an atrial extract Science (Washington) 224 1984 992 994
2. 2 receptors J Neurochem 64 1995 1080 1087
3. A.J. de Bold, H.B. Borenstein, A.T. Veress, and H. Sonnenberg A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats Life Sci 28 1981 89 94
4. M.-S. Chang, D.G. Lowe, M. Lewis, R. Hellmiss, E. Chen, and D.V. Goeddel Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases Nature (London) 341 1989 68 72
5. M. Chinkers, D.L. Garbers, M.-S. Chang, D.G. Lowe, H. Chin, and D.V. Goeddel A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor Nature (London) 338 1988 78 83
6. 2+ channels in two secretory cell lines, PC12 and RINm5F J Biol Chem 261 1986 32 35
7. R. Garcia, G. Thibault, M. Cantin, and J. Genest Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds Am J Physiol 247 1984 R34-R39
8. J.G. Drewett, G.R. Marchand, R.J. Ziegler, and G.J. Trachte Atrial natriuretic factor inhibits norepinephrine release from an adrenergic clonal cell line (PC12) Eur J Pharmacol 150 1988 175 179
9. J.G. Drewett, R.J. Ziegler, G.R. Marchand, and G.J. Trachte Cyclic guanosine 3′,5′-monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells J Pharmacol Exp Ther 250 1989 428 432
10. J.G. Drewett, R.J. Ziegler, and G.J. Trachte Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells J Pharmacol Exp Ther 255 1990 497 503
11. X.-L. He, D.-C. Chow, M.M. Martick, and K.C. Garcia Allosteric activation of a spring-loaded natriuretic peptide receptor dimmer by hormone Science (Washington) 293 2001 1657 1662
12. J. Jaubert, F. Jaubert, N. Martin, L.L. Washburn, B.K. Lee, and E.M. Eicher Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3) Proc Natl Acad Sci USA 96 1999 10278 10283
13. 2 in rabbit isolated vas a deferentia J Pharmacol Exp Ther 257 1991 720 726
14. S. Kanwal, B.J. Elmquist, and G.J. Trachte Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium J Pharmacol Exp Ther 283 1997 426 433
15. S. Kanwal, D.G. Lowe, and G.J. Trachte Intracellular fragments of the natriuretic peptide receptor-C (NPR-C) attenuate dopamine efflux Endocrinology 140 1999 1118 1124
16. R.B. Kelly, J.W. Deutsch, S.S. Carlson, and J.A. Wagner Biochemistry of neurotransmitter release Ann Rev Neurosci 2 1979 399 446
17. D.P. Lotshaw, R. Franco-Saenz, and P.J. Mulrow Atrial natriuretic peptide inhibition of calcium ionophore A23187-stimulated aldosterone secretion in rat adrenal glomerulosa cells Endocrinology 129 1991 2305 2310
18. T. Maack, M. Suzuki, F.A. Almeida, D. Nussenzveig, R.M. Scarborough, and G.A. McEnroe Physiological role of silent receptors of atrial natriuretic factor Science (Washington) 238 1987 675 678
19. R.T. McCarthy, C.M. Isales, C.M. Bollag, H. Rasmussen, and P.Q. Berrett Atrial natriuretic peptide differentially modulates T- and L-type calcium channels Am J Physiol 258 1990 F473 F478
20. A.E. Medvedev, A. Clow, M. Sandler, and V. Glover Isatin: a link between matriuretic peptides and monoamines? Biochem Pharmacol 52 1996 385 391
21. J.E. Merritt, R. Jacob, and T.J. Hallam Use of manganese to discriminate between caldium influx and mobilization from internal stores in stimulated human neutrophils J Biol Chem 264 1989 1522 1527
22. K.S. Murthy, and G.M. Makhlouf Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C) J Biol Chem 274 1999 17587 17592
23. M. Nakamaru, and T. Inagami Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries Eur J Pharmacol 123 1986 459 461
24. i activator sequences that inhibit adenylyl cyclase activity J Biol Chem 276 2001 22064 22070
25. J.G. Porter, A. Arfsten, F. Fuller, J.A. Miller, L.C. Gregory, and J.A. Lewicki Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA Biochem Biophys Res Commun 171 1990 796 803
26. H. Portzehl, P.C. Caldwell, and J.C. Ruegg The dependence of contraction and relaxation of muscle fibres from the crab maia Squinado on the internal concentration of free calcium ions Biochem Biophys Acta 79 1964 581 591
27. F. Rodriguez-Pascual, M.T. Miras-Protugal, and M. Torres Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase Mol Pharmacol 49 1996 1058 1070
28. T. Sano, Y. Morishita, Y. Matsuda, and K. Yamada Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. 1. Selective inhibition of the actions of natriuretic peptide in anesthetized rats J Pharmacol Exp Ther 260 1992 825 831
29. oα Hypertension 33 1999 124 129
30. G.J. Trachte Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens J Pharmacol Exp Ther 264 1993 1227 1233
31. G.J. Trachte Depletion of natriuretic peptide C receptors eliminates inhibitory effects of C-type natriuretic peptide on evoked neurotransmitter efflux J Pharmacol Exp Ther 294 2000 210 215
32. G.J. Trachte Urodilation attenuates sympathetic neurotransmission in the rabbit isolated vas deferens without activating guanylyl cyclase Life Sci 69 2001 2833 2844
33. G.J. Trachte Natriuretic peptides suppress protein kinase C activity to reduce evoked dopamine efflux from pheochromocytoma (PC12) cells Endocrinology 144 2003 94 100
34. G.J. Trachte, and J.G. Drewett C-type natriuretic peptide neuromodulates independently of guanylyl cyclase activation Hypertension 23 1994 38 43
35. G.J. Trachte, S. Kanwal, B.J. Elmquist, and R.J. Ziegler C-type natriuretic peptide neuromodulates via "clearance" receptors Am J Physiol 268 1995 C978 C984
36. T.W. vonGeldern, G.P. Budzik, T.P. Dillon, W.H. Holleman, M.A. Holst, and Y. Kiso Atrial natriuretic peptide antagonists: biological evaluation and structural correlations Mol Pharmacol 38 1990 771 778
37. D.F. Wyss, H.-W. Lahm, M. Manneberg, and A.M. Labhardt Anantin - a peptide antagonist of the atrial natriuretic factor (ANF) J Antibiot 44 1991 172 180
38. H. Zhou, and K.S. Murthy Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C) Am J Physiol 284 2003 C1255 C1261